Pyxis Oncology, Inc. (PYXS) stock
PYXSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.58+0.00 (0.00%)
Close on Nov 13, 2026Market cap $131.79MP/E –Yield –
Pyxis Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Pyxis Oncology's enterprise value was $71.03M on Nov 11, 2026, against $246.26M a year earlier. Over the last 5 years it ranged from -$195.79M to $246.26M, with a median of -$36.37M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $71.03M | – |
| 2025 | Dec 31, 2025 | -$4.83M | – |
| 2024 | Dec 31, 2024 | -$52.06M | – |
| 2023 | Dec 29, 2023 | -$53.27M | – |
| 2022 | Dec 30, 2022 | -$154.87M | – |
| 2021 | Dec 31, 2021 | -$115.49M | – |
See a number that looks wrong?